抗原
免疫疗法
免疫系统
细胞毒性T细胞
CD8型
癌症研究
肿瘤异质性
癌症免疫疗法
生物
癌症
免疫学
遗传学
体外
作者
Emma Leschiera,Tommaso Lorenzi,Shensi Shen,Luís Almeida,Chloé Audebert
标识
DOI:10.1016/j.jtbi.2022.111028
摘要
The number of sub-populations of tumour cells constituting a tumour and the immunogenicity of tumour cells are two major components of intra-tumour heterogeneity (ITH), and play a key role in the immune response against solid tumours. Mathematical models make it possible to separate these two components of ITH and investigate their influence on anti-tumour immunity in a controlled manner. Here, we present a spatially explicit stochastic individual-based model of the interaction dynamics between tumour cells and CD8 + T cells. We use this model to investigate how ITH may affect the anti-tumour immune response. In our model, ITH can vary both with the number of expressed antigens (i.e. the number of sub-populations of tumour cells) and with the level of antigen presentation (i.e. the immunogenicity of the cells). Computational simulations of our model indicate that both sources of ITH affect the outcome of anti-tumour immune response. First, the number of sub-populations of tumour cells negatively correlates with the ability of the CD8 + T cells to produce an efficient anti-tumoural response. Second, the fraction of non-immunogenic cells within a tumour can significantly reduce the effectiveness of the immune response. These results qualitatively reproduce a broad range of scenarios of successful and unsuccessful immune surveillance reported in experimental studies. Ultimately, our model may provide a framework to help biologists and clinicians to better understand the prognostic outcomes of immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI